PortaCellTec biosciences GmbH

Scientific Advisory Board

 

Prof. Dr. Gerhard Burckhardt

  • Expert on organic anion transporters (OATs)

  • Professor and head of the department of Vegetative Physiology and Pathophysiology, Georg-August University Göttingen (since 1991)

  • Habilitation for physiology (1988)

  • Coordinator for graduate college cancer pharmacogenetics (gcpg  1034; 2005 - 2014)

  • Current focus: regulation and substrate binding of OAT1 and NaDC3

Link:  http://www.veg-physiol.med.uni-goettingen.de/

 

 Prof. Dr. Hermann Koepsell

  • Expert on organic cation transporters (OCTs)

  • Associate / Shareholder of PortaCellTec biosciences

  • Professor and Chairman at the department of Anatomy & Cell Biology at the University of Würzburg, Medical School (since 1993)

  • Habilitation for Biochemistry (1987)

  • Member of the American Society for Pharmacology and Experimental Therapeutics 

  • Member of German Society of Nephrology

  • Editorial Board Member: Molecular Pharmacology (since 2004)

  • Current focus: function, structure and mechanism of drug transporters

Link:  http://www.anatomie.uni-wuerzburg.de/institutelehrstuehle/lehrstuhl_fuer_anatomie_i/startseite/

 

Prof. Dr. Hannelore Daniel

  • Expert on peptide transporters

  • Professor at the Molecular Nutrition Unit, Technische Universität München (since 1999)

  • Habilitation and venia legendi for Physiology and Biochemistry of Human Nutrition (University Giessen, 1989)

  • Member of the DFG Review Board Medicine-Section 4 for Nutritional Sciences (since 2004)

  • Member of the editorial board of European Journal of Nutrition and Pfluegers Archiv

  • Current focus: Transport of di- and tripeptids

Link:  http://www.wzw.tum.de/nutrition/index.php?id=39

 

Prof. Dr. Jürgen Brockmöller

  • Expert on pharmacology and pharmacogenetic

  • Professor at the department of clinical pharmacology, Georg-August University Göttingen (since 2000)

  • Participation on Phase-I to Phase-IV studies for drug approval

  • Research on different genetic polymorphisms

  • Speaker of graduate college 1034 “Bedeutung genetischer Polymorphismen in der Onkologie: Von den Grundlagen zur individualisierten Therapie“ ( 2005 - 2014)

  • Current focus: functional pharmacogenetic and pharmacogenomic; the clinical relevance in medical application

Link: http://www.klinpharm.med.uni-goettingen.de/

 

Prof. Dr. Joachim Geyer

  • Expert on SLC10 carriers and pharmacogenetics

  • Professor at the institute of pharmacology and toxicology, Justus-Liebig- University of Giessen (since 2008)

  • Member of the German Society of clinical and experimental pharmacology and toxicology

  • Current focus: structure, regulation and substrate binding of SLC10 carriers

Link: http://www.vetmed.uni-giessen.de/pharmtox

 

About us


Team


Events


Important milestones


Scientific advisory board


Advice & assistance


Publications

PortaCellTec Biosciences GmbH

 

Weender Landstraße 94 -108
37075 Göttingen
Tel : +49 551 309 66440
E-mail: PortaCellTec



Download PortaCellTec flyer

PortaCellTec

News

New validated products:

  • mNtcp
  • mOct1

Events

3rd German Pharm-Tox Summit
Göttingen, Germany
26 February - 1 March 2018


Pharmaforum
Saarbrücken, Germany
8 March 2018

 

AAPS Workshop
Virginia, USA
16 - 18 April 2018

 

20th Barrier- and
Transporter-Meeting

Bad Herrenalb, Germany
7 - 9 May 2018

Greifswalder Transporttage 2018
Greifswald, Germany
7 - 9 September 2018

 


Guidance for Industry (FDA and EMA)

Publications